Malcolm K. Brenner

机构：Houston Methodist · ORCID：0000-0002-3657-7675

发表论文 888 篇 · 总被引 56579 次 · h-index 117

代表论文

• Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers (2024 · Nature · 被引 256)
• Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial (2024 · Nature Cancer · 被引 104)
• LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study (2024 · The Lancet Oncology · 被引 73)
• Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma (2025 · Nature Medicine · 被引 68)
• Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas (2023 · Blood · 被引 63)
• Off-the-Shelf CD19-Specific CAR-NKT Cells in Patients with Relapsed or Refractory B-Cell Malignancies (2024 · Transplantation and Cellular Therapy · 被引 27)